Windlas Biotech Limited - Asset Resilience Ratio

Latest as of September 2025: 32.06%

Windlas Biotech Limited (WINDLAS) has an Asset Resilience Ratio of 32.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs2.61 Billion

≈ $28.23 Million USD Cash + Short-term Investments

Total Assets

Rs8.14 Billion

≈ $88.05 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Windlas Biotech Limited's Asset Resilience Ratio has changed over time. Check WINDLAS strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Windlas Biotech Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see WINDLAS market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.61 Billion	32.06%
Total Liquid Assets	Rs2.61 Billion	32.06%

Asset Resilience Insights

Very High Liquidity: Windlas Biotech Limited maintains exceptional liquid asset reserves at 32.06% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Windlas Biotech Limited Industry Peers by Asset Resilience Ratio

Compare Windlas Biotech Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	Drug Manufacturers - Specialty & Generic	5.92%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Zhejiang Tianyu Pharmaceutical Co Ltd SHE:300702	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Garden Bio-chemical High-tech Co Ltd SHE:300401	Drug Manufacturers - Specialty & Generic	5.09%
KPC Pharmaceuticals Inc SHG:600422	Drug Manufacturers - Specialty & Generic	16.37%

Annual Asset Resilience Ratio for Windlas Biotech Limited (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Windlas Biotech Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	31.54%	Rs2.40 Billion ≈ $25.94 Million	Rs7.60 Billion ≈ $82.24 Million	-0.25pp
2024-03-31	31.79%	Rs1.99 Billion ≈ $21.53 Million	Rs6.26 Billion ≈ $67.72 Million	+7.54pp
2023-03-31	24.25%	Rs1.28 Billion ≈ $13.87 Million	Rs5.29 Billion ≈ $57.21 Million	-11.48pp
2022-03-31	35.73%	Rs1.75 Billion ≈ $18.97 Million	Rs4.91 Billion ≈ $53.10 Million	+22.79pp
2021-03-31	12.94%	Rs383.25 Million ≈ $4.14 Million	Rs2.96 Billion ≈ $32.02 Million	+6.27pp
2020-03-31	6.67%	Rs225.86 Million ≈ $2.44 Million	Rs3.38 Billion ≈ $36.61 Million	-0.45pp
2019-03-31	7.12%	Rs212.41 Million ≈ $2.30 Million	Rs2.98 Billion ≈ $32.25 Million	-0.76pp
2018-03-31	7.88%	Rs228.53 Million ≈ $2.47 Million	Rs2.90 Billion ≈ $31.35 Million	--

pp = percentage points

About Windlas Biotech Limited

NSE:WINDLAS India Drug Manufacturers - Specialty & Generic

Market Cap

$200.70 Million

Rs18.56 Billion INR

Market Cap Rank

#16505 Global

#869 in India

Share Price

Rs880.50

Change (1 day)

+1.03%

52-Week Range

Rs718.35 - Rs1070.80

All Time High

Rs1144.25